Walter, R. B., Buckley, S. A., Pagel, J. M., Wood, B. L., Storer, B. E., Sandmaier, B. M., . . . Appelbaum, F. R. (2013). Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission. American Society of Hematology.
Citação norma ChicagoWalter, Roland B., et al. Significance of Minimal Residual Disease Before Myeloablative Allogeneic Hematopoietic Cell Transplantation for AML in First and Second Complete Remission. American Society of Hematology, 2013.
Citação norma MLAWalter, Roland B., et al. Significance of Minimal Residual Disease Before Myeloablative Allogeneic Hematopoietic Cell Transplantation for AML in First and Second Complete Remission. American Society of Hematology, 2013.